VLA 2112
Alternative Names: VLA-2112Latest Information Update: 29 Aug 2022
At a glance
- Originator Valneva
- Class Protein vaccines; Synthetic vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Epstein-Barr virus infections